Public Health Impact of Unilateral Spatial Neglect
IMPAssNEGLECT
1 other identifier
observational
168
1 country
1
Brief Summary
This multi-center project aims to quantify the socio-medical costs associated with Unilateral Spatial Neglect (USN) resulting from acquired brain injury (stroke) and to measure the effects of USN rehabilitation on functional autonomy, quality of life and psychological well-being of patients affected by this syndrome, considering the repercussions on a psychological level and on the quality of life of caregivers. To this end, the experimenters will administer to right brain-injured patients - with (Experimental Group) or without (Control Group) USN - who undertook a rehabilitation process, a series of questionnaires: Activities of daily living (ADL), Barthel Index; Instrumental activities of daily living scale (I-ADL:), the Health Related Quality of Life questionnaire (EQ-5D-5L), the Geriatric Depression Scale (GDS), and the State-Trait Anxiety Inventory (STAI-Y). The aforementioned tests will be administered before the start of the rehabilitation (baseline) and after one month, 3, 6 and 12 months after the end of the rehabilitation. The impact of USN and its treatment on the psycho-physical well-being of the caregiver will be measured through the Caregiver Burden Inventory questionnaire, which will be administered with the same timing (baseline, 1-3-6-12 months after rehabilitation). The costs of USN will be surveyed through an ad-hoc questionnaire, which includes a version intended for patients and one for caregivers, in order to identify the resources consumed due to the disease and the expenses taken during the observation period, to be estimated subsequently in monetary terms (€).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 7, 2022
CompletedFirst Submitted
Initial submission to the registry
March 3, 2023
CompletedFirst Posted
Study publicly available on registry
March 31, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2024
CompletedMarch 31, 2023
March 1, 2023
2.8 years
March 3, 2023
March 29, 2023
Conditions
Outcome Measures
Primary Outcomes (10)
Change in the Activities of Daily Living scale (ADL)
To evaluate the degree of patients' functional independence in everyday life
At baseline (at the beginning of the treatment) and after 1, 3, 6, and 12 months after the end of the treatment
Change in the Instrumental Activities of Daily Living scale (I-ADL)
To evaluate the degree of patients' functional independence instrumental activities, including, e.g., cleaning, cooking, and managing finances.
At baseline (at the beginning of the treatment) and after 1, 3, 6, and 12 months after the end of the treatment
Change in the Health-Related Quality of Life (EQ-5D-5L)
A brief scale assessing patient's health-related quality of life
At baseline (at the beginning of the treatment) and after 1, 3, 6, and 12 months after the end of the treatment
Change in the Geriatric Depression Scale (GDS)
A scale assessing patients' depressive symptoms
At baseline (at the beginning of the treatment) and after 1, 3, 6, and 12 months after the end of the treatment
Change in the State-Trait Anxiety Inventory (STAI-Y)
A scale assessing patients' anxiety symptoms
At baseline (at the beginning of the treatment) and after 1, 3, 6, and 12 months after the end of the treatment
Change in the Caregiver Burden Inventory questionnaire (CBI)
A scale that assess caregivers' physical and psychological burden
At baseline (at the beginning of the treatment) and after 1, 3, 6, and 12 months after the end of the treatment
Financial impact of USN
A questionnaire about health-related costs associated to the disease (e.g., heath examinations, medicines, sick leaves)
1 month after the end of the treatment
Financial impact of USN
A questionnaire about health-related costs associated to the disease (e.g., heath examinations, medicines, sick leaves)
3 months after the end of the treatment
Financial impact of USN
A questionnaire about health-related costs associated to the disease (e.g., heath examinations, medicines, sick leaves)
6 months after the end of the treatment
Financial impact of USN
A questionnaire about health-related costs associated to the disease (e.g., heath examinations, medicines, sick leaves)
12 months after the end of the treatment
Study Arms (2)
Stroke patients with USN and their caregivers
Stroke patients without USN and their caregivers
Interventions
Questionnaires: * Activities of daily living - ADL * Barthel Index * Instrumental activities of daily living- IADL * Health Related Quality of Life - EQ-5D-5L * Geriatric Depression Scale (GDS) * State-Trait Anxiety Inventory - STAI-Y) * Caregiver Burden Inventory questionnaire (CBI)
Eligibility Criteria
Stroke patients with and without USN and their caregivers
You may qualify if:
- age \> 18 years;
- right brain injury due to stroke (of ischemic or hemorrhagic origin);
- Disease duration ≥ 10 days;
- Participation to a rehabilitation program;
- For stroke patients with USN:
- \- clinical diagnosis of USN, placed by the specialist of reference, on the basis of clinical indicators and the results obtained by the patient in the routine neuropsychological evaluation (by means of a battery of standardized psychometric tests calibrated in the Italian population).
You may not qualify if:
- Other brain disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istituto Auxologico Italiano IRCCS
Milan, Lombardy, 20122, Italy
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 3, 2023
First Posted
March 31, 2023
Study Start
February 7, 2022
Primary Completion
November 30, 2024
Study Completion
November 30, 2024
Last Updated
March 31, 2023
Record last verified: 2023-03